Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer Vaccines01:30

Cancer Vaccines

1.2K
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
1.2K
Vaccinations01:51

Vaccinations

52.4K
Overview
52.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Proteomic analysis of exosomes from <i>Brucella abortus</i>-infected macrophages reveals possible mechanisms of immune evasion and host modulation.

Frontiers in immunology·2025
Same author

Persistence phenotype of adherent-invasive <i>Escherichia coli</i> in response to ciprofloxacin, revealing high-persistence strains.

Microbial cell (Graz, Austria)·2025
Same author

Prevalence of Cow's Milk Allergy in Infants from an Urban, Low-Income Population in Chile: A Cohort Study.

Nutrients·2025
Same author

Diagnosis and genomic characterization of the largest western equine encephalitis virus outbreak in Uruguay during 2023-2024.

Npj viruses·2025
Same author

Concordance of <i>Helicobacter pylori</i> Detection Methods in Symptomatic Children and Adolescents.

Microorganisms·2025
Same author

Protocol for a randomised 'screen-and-treat' <i>Helicobacter pylori</i> eradication trial in 14-18-years-old adolescents residing in three regions of Chile: effectiveness and microbiological host implications.

BMJ open·2025

Related Experiment Video

Updated: Feb 27, 2026

Reverse Genetics Mediated Recovery of Infectious Murine Norovirus
13:48

Reverse Genetics Mediated Recovery of Infectious Murine Norovirus

Published on: June 24, 2012

17.3K

Norovirus vaccines under development.

Yalda Lucero1, Roberto Vidal2, Miguel O'Ryan G3

  • 1Microbiology and Mycology Program, Institute of Biomedical Sciences, Faculty of Medicine, University of Chile, Santiago, Chile; Department of Pediatrics, Hospital Luis Calvo Mackenna, Faculty of Medicine, University of Chile, Santiago, Chile; Pediatric Gastroenterology Unit, Department of Pediatrics, Faculty of Medicine, Clínica Alemana-Universidad del Desarrollo, Santiago, Chile.

Vaccine
|July 3, 2017
PubMed
Summary

Developing vaccines against Noroviruses (NoVs), a major cause of gastroenteritis, faces challenges like viral diversity. Current vaccine candidates utilize virus-like particles (VLPs) and are in early clinical development.

Keywords:
Acute gastroenteritisHuman calicivirusNorovirusVaccine

More Related Videos

Generation of Recombinant Arenavirus for Vaccine Development in FDA-Approved Vero Cells
10:03

Generation of Recombinant Arenavirus for Vaccine Development in FDA-Approved Vero Cells

Published on: August 1, 2013

17.7K
Detection and Genogrouping of Noroviruses from Children's Stools By Taqman One-step RT-PCR
15:16

Detection and Genogrouping of Noroviruses from Children's Stools By Taqman One-step RT-PCR

Published on: July 22, 2012

17.9K

Related Experiment Videos

Last Updated: Feb 27, 2026

Reverse Genetics Mediated Recovery of Infectious Murine Norovirus
13:48

Reverse Genetics Mediated Recovery of Infectious Murine Norovirus

Published on: June 24, 2012

17.3K
Generation of Recombinant Arenavirus for Vaccine Development in FDA-Approved Vero Cells
10:03

Generation of Recombinant Arenavirus for Vaccine Development in FDA-Approved Vero Cells

Published on: August 1, 2013

17.7K
Detection and Genogrouping of Noroviruses from Children's Stools By Taqman One-step RT-PCR
15:16

Detection and Genogrouping of Noroviruses from Children's Stools By Taqman One-step RT-PCR

Published on: July 22, 2012

17.9K

Area of Science:

  • Virology and Immunology
  • Vaccine Development
  • Public Health

Background:

  • Noroviruses (NoVs) are a primary cause of acute gastroenteritis globally, affecting all age groups.
  • High-risk populations include young children, the elderly, and individuals in crowded settings.
  • Effective preventive strategies, particularly vaccines, are needed to mitigate NoV burden.

Purpose of the Study:

  • To review the significant challenges hindering Norovirus vaccine development.
  • To discuss the current status and types of Norovirus vaccine candidates.
  • To highlight the need for effective vaccines against diverse Norovirus strains.

Main Methods:

  • Review of existing literature on Norovirus vaccine research and development.
  • Analysis of challenges including genetic diversity, immunology, and lack of suitable models.
  • Examination of vaccine platforms such as virus-like particles (VLPs), P-particles, and viral vectors.

Main Results:

  • Norovirus vaccine development is impeded by extensive viral genetic and antigenic diversity.
  • Limited understanding of Norovirus immunology and replication cycles poses a significant hurdle.
  • Absence of a permissive cell line and a robust animal model complicates research.

Conclusions:

  • Despite challenges, promising vaccine candidates, primarily VLP-based, are progressing.
  • One VLP vaccine candidate has advanced to Phase II clinical trials.
  • Further research and development are crucial for a broadly protective Norovirus vaccine.